Medical oncology
1 – 10 of 410
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Fachal, Laura ; Borg, Åke LU ; Olsson, Håkan LU
and
Dunning, Alison M
(2020)
In Nature Genetics
52(1).
p.56-73
Mark
-
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Escala-Garcia, Maria ; Brenner, Hermann LU ; Ellberg, Carolina LU
;
Olsson, Håkan
LU
;
Hall, Per
LU
;
Canisius, Sander
and
Schmidt, Marjanka K
(2020)
In Nature Communications
11(1).
Mark
- Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study
- The Menstrual Cycle and Risk of Breast Cancer : A Review
- Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy : an international study of 264 real-world patients
-
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.
Feng, Helian ; Borg, Åke LU ; Olsson, Håkan LU
and
Ellberg, Carolina
LU
(2020)
In Genetic Epidemiology
Mark
-
Desloratadine and loratadine use associated with improved melanoma survival
Fritz, Ildikó LU ; Wagner, Philippe LU ; Bottai, Matteo ; Eriksson, Hanna ; Ingvar, Christian LU ; Krakowski, Isabelle ; Nielsen, Kari LU
and
Olsson, Håkan
LU
(2020)
In Allergy
Mark
- Detection of HPV mRNA in Self-collected Vaginal Samples Among Urban Ethiopian Women
- Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study
-
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
Fritz, Ildikó LU ; Wagner, Philippe LU ; Broberg, Per LU ; Einefors, Rickard and Olsson, Håkan LU
(2020)
In Acta oncologica (Stockholm, Sweden)
p.1-7
Mark